Home Syracuse University College of Law NYSTAR - New York State Foundation for Science, Technology & Innovation

Katalytik Inc.

1. What is Katalytik?

Currently, information technology in healthcare shows little to no tangible impact in improving patient care. Katalytik Inc. is a company that develops software enterprise applications targeted to solve this fundamental and widespread problem.

2. How was Katalytik created? What relationships, university affiliations and/or collaborative efforts were involved?

Katalytik was founded by Dr. Anwar Hussain MD, MHA. His experience in clinical medicine led to other experiences that, in turn, led to the company’s formation. There were no affiliations at its outset, but there are affiliations now. Our current academic collaborators include faculty from Stanford University, Harvard University, Arizona State University and Binghamton University. Team members came together mainly through the common passion of trying to build technology that can have a measurable impact on patient care. We got together mainly by networking through personal contacts, although LinkedIn was helpful in locating non-management members.

3. At what stage of the technology’s development did Katalytik first start collaborating with a university?

The company started collaborating with faculty at universities once the pilot site had been chosen. We are currently doing our pilot at the emergency department at United Health Services in Johnson City, NY.

4. Does Katalytik have an ongoing relationship with a university or its researchers? What are the advantages to working with a university?

We have active relationships with several university faculty members, as described above. The advantages of working with faculty include research and publication, sharing of ideas, and having their involvement in the testing of new ideas.

5. Would you briefly describe Katalytik’s business plan? 

Katalytik’s business focus is to create enterprise software applications that are sold primarily to hospitals. The initial target customers are the emergency departments and the inpatient medicine departments of hospitals. Currently, the focus is on customers in the United States; there are approximately 4,000 ERs and 5,000 hospitals in the country.

6. What is the current status of Katalytik? In what research and development efforts has Katalytik recently been engaged?

Katalytik is currently conducting a pilot project in the emergency department of United Health Services. Our pilot will likely finish by the second half of 2009. The goal of the pilot project is to implement a working version of the system into a live emergency department in order to measure its effects. The project’s ultimate goal is to improve/alleviate the effects of emergency department overcrowding on both patients and providers. ER overcrowding can easily be classified as a public health crisis because of its widespread nature (i.e., over 90% of U.S. ERs report overcrowding) and because of its effects (e.g., patients have died due to delays in treatment in some cases).

7. Who is on the Katalytik team?

The company’s management team is comprised of the following members: Anwar Hussain MD, MHA (Founder, CEO) Joe Falcone MS (VP, Engineering) Dan Berrios MD, PhD, MPH (Chief Technology Officer) Ram Duriseti MD, PhD (Medical Director)

8. How was Katalytik named?

Katalytik was named as a play on the word “catalytic”. The idea was to refer to building products and tools that can help catalyze efficiency in the healthcare system – arguably the most inefficient vertical of the U.S. economy.